Nyheter/rapporter

Senaste pressmeddelanden och rapporter för bevakat bolag.

Datum Källa Rubrik Typ Alternativ
2022-08-11 Immunovia Immunovia AB: Immunovia, Inc. erhåller licencsrättigheter från hälsodepartementet i Kalifornien för IMMray® PanCan-d-test Pressreleaser Ladda ner | Visa Stäng
2022-08-11 Immunovia Immunovia AB: Immunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray™ PanCan-d test Pressreleaser Ladda ner | Visa Stäng
2022-07-05 Immunovia Immunovia AB: CPT PLA-kod för testet IMMray® PanCan-d godkänt Pressreleaser Ladda ner | Visa Stäng
2022-07-05 Immunovia Immunovia AB: CPT PLA Code for the IMMray™ PanCan-d test approved Pressreleaser Ladda ner | Visa Stäng
2022-06-30 Immunovia Immunovia AB: The PanDIA-1 study, for early detection of pancreatic cancer in newly onset type 2 diabetics, moves into next phase Pressreleaser Ladda ner | Visa Stäng
2022-06-30 Immunovia Immunovia AB: PanDIA-1-studien för tidig upptäckt av bukspottkörtelcancer vid typ 2-diabetes går vidare till nästa fas Pressreleaser Ladda ner | Visa Stäng
2022-06-27 Immunovia Immunovia AB: Inbjudan till Immunovias presentation av resultat för PanFAM-1 Pressreleaser Ladda ner | Visa Stäng
2022-06-27 Immunovia Immunovia AB: Invitation to Immunovia's Presentation of PanFAM-1 Results Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 27 Jun 2022 | Immunovia

Immunovia AB: Invitation to Immunovia’s Presentation of PanFAM-1 Results

Philipp Matieu, CEO and President, Thomas King, Medical Director, and Jeff Borcherding, CEO US operations, will present. The presentation will be held in English and be followed by a Q&A session. You are welcome to join via webcast or phone, see details below.

Telephone numbers and webcast

Ring any of the numbers below to participate via telephone. Please dial in a few minutes before the presentation starts.

Sweden: +46 8 50 51 00 31

United Kingdom: +44 207 107 06 13

United States: +1 631 570 56 13

Link to the webcast: https://creo-live.creomediamanager.com/806a27cb-a49a-4fa9-b7e7-3ac9fd7a4795

To ask questions, it is necessary to dial in. A recording of the presentation will be available on Immunovia’s website.

For more information, please contact:
Tobias Bülow
Senior Director Investor Relations and Corporate Communications
tobias.bulow@immunovia.com
+46736 36 35 74

The information was submitted for publication on June 27, 2022, at 09:00 am CET.

About Immunovia
Immunovia AB is a diagnostic company with the vision to revolutionize blood-based diagnostics and increase survival rates for patients with cancer.

Our first product, IMMray™ PanCan-d is the only blood test currently available specifically for the early detection of pancreatic cancer. The test has unmatched clinical performance. Commercialization of IMMray™ PanCan-d started in August 2021 in the USA and IMMray™ PanCan-d is offered as a laboratory developed test (LDT) exclusively through Immunovia, Inc. For more information see: www.immunoviainc.com.

Immunovia collaborates and engages with healthcare providers, leading experts and patient advocacy groups globally to make this test available to all high-risk pancreatic cancer groups. 

The USA, the first market in which IMMray™ PanCan-d is commercially available, is the world’s largest market for the detection of pancreatic cancer with an estimated value of more than USD 4 billion annually.

Immunovia’s shares (IMMNOV) are listed on Nasdaq Stockholm. For more information, please visitwww.immunovia.com.

                                                                           ###

2022-06-27 Immunovia Immunovia AB: PanFAM-1 Results Partly Inconclusive Pressreleaser Ladda ner | Visa Stäng
2022-06-27 Immunovia Immunovia AB: Resultat för PanFAM-1 delvis ofullständigt Pressreleaser Ladda ner | Visa Stäng
2022-06-02 Immunovia Philipp Mathieu utnämnd till vd för Immunovia AB Pressreleaser Ladda ner | Visa Stäng
2022-06-02 Immunovia Philipp Mathieu appointed CEO of Immunovia AB Pressreleaser Ladda ner | Visa Stäng
2022-05-23 Immunovia Immunovia AB: Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states Pressreleaser Ladda ner | Visa Stäng
2022-05-23 Immunovia Immunovia AB: Ökad marknadstillgång när Immunovia, Inc. erhåller licensrättigheter för kliniska laboratorier från Pennsylvanias och Marylands hälsodepartement Pressreleaser Ladda ner | Visa Stäng
2022-05-17 Immunovia Immunovia AB: Immunovia, Inc. erhåller licensrättigheter för kliniska laboratorier från Rhode Islands hälsodepartement vilket gör testet IMMray® PanCan-d tillgängligt i 46 amerikanska delstater Pressreleaser Ladda ner | Visa Stäng
2022-05-17 Immunovia Immunovia AB: Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states Pressreleaser Ladda ner | Visa Stäng
2022-05-16 Immunovia Immunovia AB: Immunovia stärker sitt amerikanska team genom utnämningen av Natalie Carfora till Head of Market Access US Pressreleaser Ladda ner | Visa Stäng
2022-05-16 Immunovia Immunovia AB: Immunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access US Pressreleaser Ladda ner | Visa Stäng
2022-04-28 Immunovia Immunovia AB: Immunovia Publishes Interim Report January-March 2022 Rapporter Ladda ner | Visa Stäng
2022-04-28 Immunovia Immunovia AB: Immunovia publicerar Delårsarapport januari-mars 2022 Rapporter Ladda ner | Visa Stäng
2022-04-21 Immunovia Immunovia AB: Inbjudan till Immunovias presentation av Q1 Pressreleaser Ladda ner | Visa Stäng
2022-04-21 Immunovia Immunovia AB: Invitation to Immunovia's Q1 presentation Pressreleaser Ladda ner | Visa Stäng
2022-04-14 Immunovia Immunovia AB: Immunovias ansökan om CPT® PLA-kod för testet IMMray™ PanCan-d på agendan hos American Medical Association Pressreleaser Ladda ner | Visa Stäng
2022-04-14 Immunovia Immunovia AB: Immunovia CPT PLA Code submission for the IMMray™ PanCan-d test is on the agenda of American Medical Association Pressreleaser Ladda ner | Visa Stäng
2022-04-07 Immunovia Kommuniké från årsstämma i Immunovia AB Pressreleaser Ladda ner | Visa Stäng
2022-04-07 Immunovia Communiqué from the Annual General Meeting in Immunovia AB Pressreleaser Ladda ner | Visa Stäng
2022-03-28 Immunovia Immunovia AB: Immunovia utser Jeff Borcherding, tidigare marknadschef på Myriad Genetics, till att leda Immunovias USA-verksamhet Pressreleaser Ladda ner | Visa Stäng
2022-03-28 Immunovia Immunovia AB: Immunovia appoints Jeff Borcherding, previously Chief Marketing Officer at Myriad Genetics, to lead Immunovia's US business Pressreleaser Ladda ner | Visa Stäng
2022-03-10 Immunovia Immunovia AB: Immunovia publicerar årsredovisningen för 2021 Pressreleaser Ladda ner | Visa Stäng
2022-03-10 Immunovia Immunovia AB: Immunovia publishes the annual report for 2021 Pressreleaser Ladda ner | Visa Stäng
2022-03-08 Immunovia Immunovia AB: Immunovia, Inc:s laboratorium erhåller ackreditering från College of American Pathologists - ett betydande steg i den rikstäckande utrullningen av IMMray® PanCan-d i USA Pressreleaser Ladda ner | Visa Stäng
2022-03-08 Immunovia Immunovia AB: Immunovia, Inc. Laboratory Receives Accreditation from College of American Pathologists - a major step in the nationwide US roll-out of IMMray™ PanCan-d Pressreleaser Ladda ner | Visa Stäng
2022-03-07 Immunovia Immunovia AB: Immunovia further strengthens IP portfolio for its IMMray™ PanCan-d signature Pressreleaser Ladda ner | Visa Stäng
2022-03-07 Immunovia Immunovia AB: Immunovia stärker IP-portföljen ytterligare för IMMray® PanCan-d-signaturen Pressreleaser Ladda ner | Visa Stäng
2022-03-04 Immunovia Notice to the Annual General Meeting of Immunovia AB (publ) Pressreleaser Ladda ner | Visa Stäng
2022-03-04 Immunovia Kallelse till årsstämma i Immunovia AB (publ) Pressreleaser Ladda ner | Visa Stäng
2022-02-22 Immunovia Immunovia AB: Immunovia invited to the 42nd Annual Cowen Health Care Conference Pressreleaser Ladda ner | Visa Stäng
2022-02-22 Immunovia Immunovia AB: Immunovia bjuds in till Cowens 42:a årliga hälso- och sjukvårdskonferens Pressreleaser Ladda ner | Visa Stäng
2022-02-17 Immunovia Immunovia AB: Immunovia publicerar Bokslutskommuniké 2021 Rapporter Ladda ner | Visa Stäng
2022-02-17 Immunovia Immunovia AB: Immunovia Publishes Full Year Report 2021 Rapporter Ladda ner | Visa Stäng
2022-02-17 Immunovia Immunovia AB: IMMray® PanCan-d - referensgranskad, blinda valideringsstudien publicerad i Clinical and Translational Gastroenterology Pressreleaser Ladda ner | Visa Stäng
2022-02-17 Immunovia Immunovia AB: IMMray™ PanCan-d - peer-reviewed, blinded validation study now published in Clinical and Translational Gastroenterology Pressreleaser Ladda ner | Visa Stäng
2022-02-04 Immunovia Immunovia AB: Inbjudan till Immunovias presentation av Q4 Pressreleaser Ladda ner | Visa Stäng
2022-02-04 Immunovia Immunovia AB: Invitation to Immunovia's Q4 presentation Pressreleaser Ladda ner | Visa Stäng
2022-02-03 Immunovia Immunovia AB: Immunovia postpones Annual General Meeting pending the Temporary Meetings Act Pressreleaser Ladda ner | Visa Stäng
2022-02-03 Immunovia Immunovia AB: Immunovia flyttar fram årsstämman beroende på den tillfälliga stämmolagen Pressreleaser Ladda ner | Visa Stäng
2022-01-20 Immunovia Immunovia AB: Immunovia appoints Philipp Mathieu as Acting CEO Pressreleaser Ladda ner | Visa Stäng
2022-01-20 Immunovia Immunovia AB: Immunovia utser Philipp Mathieu som tillförordnad vd Pressreleaser Ladda ner | Visa Stäng
2021-11-30 Immunovia Immunovia AB: Immunovia's CEO to step down during 2022 Pressreleaser Ladda ner | Visa Stäng
2021-11-26 Immunovia Immunovia AB: Immunovia appoints new Senior Director Investor Relations and Corporate Communications Pressreleaser Ladda ner | Visa Stäng
2021-11-26 Immunovia Immunovia AB: Immunovia utser ny Senior Director Investor Relations and Corporate Communications Pressreleaser Ladda ner | Visa Stäng
2021-11-23 Immunovia Immunovia AB: Immunovia högtidliggjorde World Pancreatic Cancer Day genom att fira invigningen av det amerikanska dotterbolaget Immunovia, Inc. Pressreleaser Ladda ner | Visa Stäng
2021-11-23 Immunovia Immunovia AB: Immunovia Honored World Pancreatic Cancer Day by a Grand Opening Celebration of the US Subsidiary Immunovia, Inc. Pressreleaser Ladda ner | Visa Stäng
2021-11-11 Immunovia Immunovia AB: Immunovia Publishes Report for the Third Quarter 2021 Rapporter Ladda ner | Visa Stäng
2021-11-11 Immunovia Immunovia AB: Immunovia publicerar rapport för tredje kvartalet 2021 Rapporter Ladda ner | Visa Stäng
2021-11-05 Immunovia Immunovia AB: Immunovia to Present at Jefferies London Healthcare Conference Pressreleaser Ladda ner | Visa Stäng
2021-11-05 Immunovia Immunovia AB: Immunovia presenterar på Jefferies London Healthcare Conference Pressreleaser Ladda ner | Visa Stäng
2021-10-29 Immunovia Immunovia AB: Immunovia, Inc.'s Medical Director Dr. Thomas King inbjuden som huvudtalare av US National Cancer Institute Pressreleaser Ladda ner | Visa Stäng
2021-10-29 Immunovia Immunovia AB: Immunovia, Inc.'s Medical Director Dr. Thomas King Invited as Keynote Speaker by US National Cancer Institute Pressreleaser Ladda ner | Visa Stäng
2021-10-29 Immunovia Immunovia AB: Inbjudan till presentation av Immunovias delårsrapport januari - september 2021 Pressreleaser Ladda ner | Visa Stäng
2021-10-29 Immunovia Immunovia AB: Invitation to Presentation of Immunovia's Interim Report January - September 2021 Pressreleaser Ladda ner | Visa Stäng
2021-10-28 Immunovia Immunovia AB: Immunovia tilldelas utmärkelsen Presidential Poster Award vid American College of Gastroenterology's årliga vetenskapskonferens Pressreleaser Ladda ner | Visa Stäng
2021-10-28 Immunovia Immunovia AB: Immunovia receives Presidential Poster Award at the American College of Gastroenterology Annual Scientific Meeting Pressreleaser Ladda ner | Visa Stäng
2021-10-25 Immunovia Valberedning utsedd inför årsstämma 2022 i Immunovia AB (Publ) Pressreleaser Ladda ner | Visa Stäng
2021-10-25 Immunovia Nomination Committee appointed for the 2022 Annual General Meeting of Immunovia AB (Publ) Pressreleaser Ladda ner | Visa Stäng
2021-10-15 Immunovia Immunovia AB: Immunovia utser ny Chief Financial Officer Pressreleaser Ladda ner | Visa Stäng
2021-10-15 Immunovia Immunovia AB: Immunovia Appoints New Chief Financial Officer Pressreleaser Ladda ner | Visa Stäng
2021-09-24 Immunovia Immunovia AB: Vator Securities: Unleashing a paradigm shift in early detection of pancreatic cancer Pressreleaser Ladda ner | Visa Stäng
2021-09-14 Immunovia Immunovia AB: USA-baserade Pancreatic Cancer Action Network informerar sina medlemmar om Immunovias blodtest IMMray® PanCan-d Pressreleaser Ladda ner | Visa Stäng
2021-09-14 Immunovia Immunovia AB: The US based Pancreatic Cancer Action Network informs their members about Immunovia's blood test IMMray™ PanCan-d Pressreleaser Ladda ner | Visa Stäng
2021-09-13 Immunovia Immunovia AB: Immunovia enters licensing agreement with JW BioScience for pancreatic cancer biomarkers Pressreleaser Ladda ner | Visa Stäng
2021-09-13 Immunovia Immunovia AB: Immunovia ingår licensavtal med JW BioScience avseende biomarkörer för bukspottkörtelcancer Pressreleaser Ladda ner | Visa Stäng
2021-09-03 Immunovia Immunovia AB: Styrelseledamot i Immunovia köper aktier i bolaget Pressreleaser Ladda ner | Visa Stäng
2021-09-03 Immunovia Immunovia AB: Board member of Immunovia purchases shares in the company Pressreleaser Ladda ner | Visa Stäng
2021-08-19 Immunovia Immunovia AB: Immunovia Publishes Report for the Second Quarter 2021 Rapporter Ladda ner | Visa Stäng
2021-08-19 Immunovia Immunovia AB: Immunovia publicerar rapport för andra kvartalet 2021 Rapporter Ladda ner | Visa Stäng
2021-08-11 Immunovia Immunovia AB: Invitation to Presentation of Immunovia's Interim Report January - June 2021 Pressreleaser Ladda ner | Visa Stäng
2021-08-11 Immunovia Immunovia AB: Inbjudan till presentation av Immunovias delårsrapport januari - juni 2021 Pressreleaser Ladda ner | Visa Stäng
2021-08-10 Immunovia Immunovia AB: Immunovia presenterar listpris för IMMray® PanCan-d i USA och förbättrad prestanda i den familjära/ärftliga riskgruppen Pressreleaser Ladda ner | Visa Stäng
2021-08-10 Immunovia Immunovia AB: Immunovia Provides Updates on the Price for the IMMray[TM] PanCan-d Test in the US and Improved Test Performance in the Familial/Hereditary Risk Group Pressreleaser Ladda ner | Visa Stäng
2021-08-04 Immunovia Immunovia AB: Immunovia Inc. får godkänt att använda testet IMMray® PanCan-d för tidig upptäckt av bukspottkörtelcancer i USA Pressreleaser Ladda ner | Visa Stäng
2021-08-04 Immunovia Immunovia AB: Immunovia, Inc. Receives Approval to Begin Testing Patients for Pancreatic Cancer with the IMMray™ PanCan-d Test Pressreleaser Ladda ner | Visa Stäng
2021-06-30 Immunovia Immunovia AB: Immunovia, Inc. erhåller lagstadgat registreringsbevis - licensieringen av laboratoriet pågår fortfarande Pressreleaser Ladda ner | Visa Stäng
2021-06-30 Immunovia Immunovia AB: Immunovia, Inc. Receives Certificate of Registration - Clinical Laboratory Licensure Still Pending Pressreleaser Ladda ner | Visa Stäng
2021-05-28 Immunovia Immunovia AB: Verkställande direktör Patrik Dahlen köper aktier i Immunovia Pressreleaser Ladda ner | Visa Stäng
2021-05-28 Immunovia Immunovia AB: CEO Patrik Dahlen purchases Immunovia shares Pressreleaser Ladda ner | Visa Stäng
2021-05-27 Immunovia Immunovia AB: Immunovia to Host a Key Opinion Leader Event on the Clinical Use of IMMray™ PanCan-d Pressreleaser Ladda ner | Visa Stäng
2021-05-27 Immunovia Immunovia AB: Immunovia bjuder in till key opinion leader event om den kliniska användningen av IMMray® PanCan-d Pressreleaser Ladda ner | Visa Stäng
2021-05-20 Finansinspektionen Finansinspektionen: Flaggningsmeddelande i Immunovia AB (publ) Pressreleaser Visa Stäng
2021-05-12 Immunovia Immunovia AB: Styrelseledamot i Immunovia köper aktier i bolaget Pressreleaser Ladda ner | Visa Stäng
2021-05-12 Immunovia Immunovia AB: Member of Immunovia's Board of Directors purchases shares in the company Pressreleaser Ladda ner | Visa Stäng
2021-05-06 Immunovia Annual General Meeting - Immunovia AB Pressreleaser Ladda ner | Visa Stäng
2021-05-06 Immunovia Kommuniké från årsstämma i Immunovia AB Pressreleaser Ladda ner | Visa Stäng
2021-05-04 Immunovia Immunovia AB: Members of Immunovia's Board of Directors purchase shares in the company Pressreleaser Ladda ner | Visa Stäng
2021-05-04 Immunovia Immunovia AB: Styrelseledamöter i Immunovia köper aktier i bolaget Pressreleaser Ladda ner | Visa Stäng
2021-04-29 Finansinspektionen Finansinspektionen: Flaggningsmeddelande i Immunovia AB (publ) Pressreleaser Visa Stäng
2021-04-28 Immunovia Immunovia AB: Immunovia publicerar delårsrapport januari - mars 2021 Rapporter Ladda ner | Visa Stäng
2021-04-28 Immunovia Immunovia AB: Immunovia Reports Interim Report January - March 2021 Rapporter Ladda ner | Visa Stäng
2021-04-22 Immunovia Immunovia AB: Immunovias process för att uppnå kostnadsersättning för IMMray[®] PanCan-d Pressreleaser Ladda ner | Visa Stäng
2021-04-22 Immunovia Immunovia AB: Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test Pressreleaser Ladda ner | Visa Stäng
2021-04-21 Immunovia Immunovia AB: Immunovia presenterar uppdatering av marknadens storlek i USA för IMMray® PanCan-d i den familjära/ärftliga riskgruppen Pressreleaser Ladda ner | Visa Stäng
2021-04-21 Immunovia Immunovia AB: Immunovia presents update on US market size for IMMray™ PanCan-d in the familial/hereditary risk group Pressreleaser Ladda ner | Visa Stäng
2021-04-21 Immunovia Immunovia AB: Inbjudan till presentation av Immunovias delårsrapport januari - mars 2021 Pressreleaser Ladda ner | Visa Stäng
2021-04-21 Immunovia Immunovia AB: Invitation to Presentation of Immunovia's Interim Report January - March 2021 Pressreleaser Ladda ner | Visa Stäng
2021-04-16 Immunovia Immunovia AB: IMMray™ PanCan-d highlighted in meeting arranged by Pancreatic Cancer Action Network Pressreleaser Ladda ner | Visa Stäng
2021-04-16 Immunovia Immunovia AB: IMMray[®] PanCan-d uppmärksammades i möte arrangerat av Pancreatic Cancer Action Network Pressreleaser Ladda ner | Visa Stäng
2021-03-31 Immunovia Immunovia AB: KALLELSE TILL ÅRSSTÄMMA I IMMUNOVIA AB Pressreleaser Ladda ner | Visa Stäng
2021-03-29 Immunovia Immunovia AB: Immunovia rapporterar förbättrad testprestanda för IMMray ® PanCan-d för upptäckt av bukspottkörtelcancer i tidigt stadium hos högriskpatienter med symptom Pressreleaser Ladda ner | Visa Stäng
2021-03-29 Immunovia Immunovia AB: Immunovia reports positive results of the blinded clinical validation of IMMray[TM] PanCan-d blood test in USA Pressreleaser Ladda ner | Visa Stäng
2021-03-29 Immunovia Immunovia AB: Immunovia reports improved test performance of IMMray[TM] PanCan-d in detecting early stage pancreatic cancer in high risk symptomatic patients Pressreleaser Ladda ner | Visa Stäng
2021-03-29 Immunovia Immunovia AB: Immunovia rapporterar positiva resultat för IMMray ® PanCan-d blodbaserade test i blindad klinisk valideringsstudie utförd i USA Pressreleaser Ladda ner | Visa Stäng
2021-03-29 Immunovia Immunovia AB: Vator Securities: Thou shall reimburse the one who finds the silent killer Pressreleaser Ladda ner | Visa Stäng
2021-03-12 Immunovia Immunovia AB: Immunovia publicerar årsredovisningen för räkenskapsåret 2020 Rapporter Ladda ner | Visa Stäng
2021-03-12 Immunovia Immunovia AB: Immunovia publishes the annual report for the financial year 2020 Rapporter Ladda ner | Visa Stäng
2021-02-26 Immunovia Immunovia AB: Immunovia publishes data sets on the Optimization Study and Commercial Test Model Study Pressreleaser Ladda ner | Visa Stäng
2021-02-26 Immunovia Immunovia AB: Immunovia publicerar datan från Optimeringsstudien och Commercial Test Model Study Pressreleaser Ladda ner | Visa Stäng
2021-02-17 Immunovia Immunovia AB: Immunovia Full Year Report 2020 Rapporter Ladda ner | Visa Stäng
2021-02-17 Immunovia Immunovia AB: Immunovia Bokslutskommuniké 2020 Rapporter Ladda ner | Visa Stäng
2021-02-15 Immunovia Immunovia AB: Immunovias PanFAM-1 prospektiva studie samlar över 3000 prover från patienter med risk för familjär/ärftlig bukspottkörtelcancer för analys under andra halvåret 2021 Pressreleaser Ladda ner | Visa Stäng
2021-02-15 Immunovia Immunovia AB: Immunovia's PanFAM-1 Prospective Study Gathers Over 3000 Familial Hereditary Pancreatic Cancer Risk Samples And Will Be Analysed In The Second Half Of 2021 Pressreleaser Ladda ner | Visa Stäng
2021-02-15 Finansinspektionen Finansinspektionen: Flaggningsmeddelande i Immunovia AB (publ) Pressreleaser Visa Stäng
2021-02-11 Immunovia Immunovia AB: Inbjudan till presentation av Immunovia's bokslutskommuniké 2020 den 17 februari 2021 Pressreleaser Ladda ner | Visa Stäng
2021-02-11 Immunovia Immunovia AB: Invitation to presentation of Immunovia's Full Year Report 2020 on February 17, 2021 Pressreleaser Ladda ner | Visa Stäng
2021-02-10 Immunovia Immunovia AB: Immunovia på väg mot försäljningsstart av IMMray ® PanCan-d under första kvartalet, 2021 Pressreleaser Ladda ner | Visa Stäng
2021-02-10 Immunovia Immunovia AB: Immunovia On Track For IMMray™ PanCan-d Sales Start In Q1 2021 Pressreleaser Ladda ner | Visa Stäng
2021-01-19 Immunovia Immunovia AB: Verkställande direktör Patrik Dahlen köper Immunovia teckningsoptioner Pressreleaser Ladda ner | Visa Stäng
2021-01-19 Immunovia Immunovia AB: Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants Pressreleaser Ladda ner | Visa Stäng
2021-01-07 Immunovia Immunovia AB: Proteomdata baserade på Immunovias IMMray® -plattform möjliggör differentialdiagnos av svårbedömda autoimmuna sjukdomar Pressreleaser Ladda ner | Visa Stäng
2021-01-07 Immunovia Immunovia AB: Proteomic data derived from Immunovia's IMMray™-platform allows differential diagnosis of difficult to distinguish autoimmune diseases Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

24 Aug 2022 | Kvartalsrapport 2022-Q2
10 Nov 2022 | Kvartalsrapport 2022-Q3
9 Feb 2023 | Bokslutskommuniké 2022